Abselion Appoints Dale Gordon as Chair [Yahoo! Finance]
Arrowhead Pharmaceuticals, Inc. (ARWR)
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arrowheadpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
CAMBRIDGE, England & CAMBRIDGE, Mass., March 23, 2026 BUSINESS WIRE )--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has appointed Dale Gordon as Chair of the Board of Directors. His appointment strengthens governance and board-level expertise at Abselion, adding experienced commercial and bioprocess leadership as the company builds on the recent establishment of its US subsidiary and continues to develop its global engagement. Abselion is committed to building a well-governed organisation that can support collaboration and reliable delivery as interest in its Amperia ™ protein quantification system grows internationally. As Chair, Dale will help to ensure sustainable growth and long-term value creation to meet the needs of academic, biotech, and pharma teams working across biologics characterisation, development, and manufacturing workflows. Dale brings more than 30 years' experience across the
Show less
Read more
Impact Snapshot
Event Time:
ARWR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARWR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARWR alerts
High impacting Arrowhead Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ARWR
News
- SRPT Stock Surges on Promising Early Results From siRNA Programs [Yahoo! Finance]Yahoo! Finance
- Arrowhead Pharmaceuticals: Transition Phase With Moderate Upside Ahead [Seeking Alpha]Seeking Alpha
- Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets [Yahoo! Finance]Yahoo! Finance
- Arrowhead Pharmaceuticals (ARWR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $100.00 price target on the stock.MarketBeat
- Arrowhead Pharmaceuticals Inc. (ARWR): Billionaire Ken Fisher Bets Big on Pharma [Yahoo! Finance]Yahoo! Finance
ARWR
Earnings
- 2/5/26 - Miss
ARWR
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form 8-K
- 3/9/26 - Form 4
- ARWR's page on the SEC website